Published Online
on March 13, 2003

A more recent version of this article appeared on April 1, 2003

This Article Full Text (PDF) All Versions of this Article: 34/4/1010    most recent 01.STR.0000062888.90293.AAv1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Filippi, A. Articles by Mazzaglia, G. Search for Related Content PubMed PubMed Citation Articles by Filippi, A. Articles by Mazzaglia, G. Related Collections Secondary prevention Cerebrovascular disease/stroke Anticoagulants Other Stroke Treatment - Medical Epidemiology

Submitted on October 14, 2002
Accepted on October 29, 2002

Secondary Prevention of Stroke in Italy. A Cross-Sectional Survey in Family Practice

Alessandro Filippi MD; Angelo Antonio Bignamini PhD; Emiliano Sessa^*; Fabio Samani MD; and Giampiero Mazzaglia MD, PhD, MSc

From the Italian College of General Practitioners (A.F., F.S.) and Health Search Database (E.S., G.M.), Florence, and School of Pharmacy (A.A.B.), University of Milan, Italy.

^* To whom correspondence should be addressed. E-mail: sessa.emiliano{at}simg.it.

Background--Hypertension control and antiplatelet or oral anticoagulant drugs are the basis for secondary prevention of cerebrovascular events. Family physicians (FPs) are usually involved in both aspects of prevention, but no research has been carried out in Italy to evaluate the behavior of FPs in this field of prevention.

Methods--Data concerning 318 Italian FPs and 465 061 patients were extracted from the Health Search Database. Patients with coded diagnoses of stroke and transient ischemic attack (TIA) were selected. Demographic records and information regarding presence of concurrent disease and medical records were also obtained. Logistic regression analyses were carried out to assess whether conditions exist that make appropriate control of blood pressure (BP) and prescription of antiplatelet or anticoagulant drugs more likely.

Results--We selected 2555 patients with diagnosis of stroke and 2755 with TIA. Among all of the subjects, 32.6% had no BP recorded. Among the remaining subjects, 58.7% reported uncontrolled BP. Isolated systolic hypertension has been shown in 68.8% of patients with uncontrolled BP. Antiplatelet and anticoagulant drugs were prescribed in 72% of these cases. Factors that made the prescription significantly more unlikely were diagnosis of TIA (odds ratio [OR], 0.47; 95% confidence interval [CI], 0.41 to 0.54), total invalidity (OR, 0.66; 95% CI 0.56 to 0.78), and time from event of 5 years or more (OR, 0.81; 95% CI, 0.70 to 0.94).

Conclusions--Italian FPs could improve secondary prevention of cerebrovascular accidents. The primary target of intervention should be the control of systolic BP, and the group of patients with unacceptably high BP should be given priority. All of these patients should have been prescribed antiplatelet drugs or anticoagulant agents, except in cases of extremely short life expectancy or substantial contraindications.

Key words: cerebrovascular accident • family practice • prevention

This article has been cited by other articles:

				G. Mazzaglia, E. Ambrosioni, M. Alacqua, A. Filippi, E. Sessa, V. Immordino, C. Borghi, O. Brignoli, A. P. Caputi, C. Cricelli, et al. Adherence to Antihypertensive Medications and Cardiovascular Morbidity Among Newly Diagnosed Hypertensive Patients Circulation, October 20, 2009; 120(16): 1598 - 1605. [Abstract] [Full Text] [PDF]

				B. Wettermark, A. Persson, and M. von Euler Secondary Prevention in a Large Stroke Population: A Study of Patients' Purchase of Recommended Drugs Stroke, October 1, 2008; 39(10): 2880 - 2885. [Abstract] [Full Text] [PDF]

				E. Touze, J. Coste, M. Voicu, J. Kansao, R. Masmoudi, B. Doumenc, P. Durieux, and J.-L. Mas Importance of In-Hospital Initiation of Therapies and Therapeutic Inertia in Secondary Stroke Prevention: IMplementation of Prevention After a Cerebrovascular evenT (IMPACT) Study Stroke, June 1, 2008; 39(6): 1834 - 1843. [Abstract] [Full Text] [PDF]

				E. Sacchetti, G. Trifiro, A. Caputi, C. Turrina, E. Spina, C. Cricelli, O. Brignoli, E. Sessa, and G. Mazzaglia Risk of stroke with typical and atypical anti-psychotics: a retrospective cohort study including unexposed subjects J Psychopharmacol, January 1, 2008; 22(1): 39 - 46. [Abstract] [PDF]

				D. A. Levine, C. I. Kiefe, T. K. Houston, J. J. Allison, E. P. McCarthy, and J. Z. Ayanian Younger Stroke Survivors Have Reduced Access to Physician Care and Medications: National Health Interview Survey From Years 1998 to 2002 Arch Neurol, January 1, 2007; 64(1): 37 - 42. [Abstract] [Full Text] [PDF]

				L. Galatti, A. Sessa, G. Mazzaglia, S. Pecchioli, A. Rossi, C. Cricelli, G. C. Schito, G. Nicoletti, and A. P. Caputi Antibiotic prescribing for acute and recurrent cystitis in primary care: a 4 year descriptive study J. Antimicrob. Chemother., March 1, 2006; 57(3): 551 - 556. [Abstract] [Full Text] [PDF]

				S. Volpato, C. Maraldi, A. Ble, M. Ranzini, A. Rita Atti, L. J. Dominguez, M. Barbagallo, R. Fellin, and G. Zuliani Prescription of Antithrombotic Therapy in Older Patients Hospitalized for Transient Ischemic Attack and Ischemic Stroke: The GIFA Study Stroke, April 1, 2004; 35(4): 913 - 917. [Abstract] [Full Text] [PDF]